Richard Harris

Award-winning journalist Richard Harris reports on science issues for NPR's newsmagazines Morning Edition, All Things Considered, and Weekend Edition.

Harris, who joined NPR in 1986, has traveled to the ends of the earth for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest and the foot of Mt. Kilimanjaro (for a story about tuberculosis).

In 2010, Harris’ reporting uncovered that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. He covered the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, followed by Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR’s award-winning 2007-2008 “Climate Connections” series.

Over the course of his career, Harris has been the recipient of many of the journalism and science industries’ most prestigious awards. The University of California at Santa Cruz awarded Harris the 2010-11 Alumni Achievement Award – the school’s highest honor. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry.

As part of the team that collaborated on NPR's 1989 series “AIDS in Black America,” Harris was awarded a Alfred I. duPont-Columbia University Silver Baton, a first place award from the National Association of Black Journalists and an Ohio State Award. In 1988, Harris won the American Association for the Advancement of Science Journalism Award for his report, “Anti-Noise: Can Technology Turn Noise into Quiet?” which explored a revolutionary technology that uses computer-generated noise to cancel out, not just mask, unwanted noise.

Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues. Under the auspices of the American Association for the Advancement of Science, Harris spent the summer of 1980 as a Mass Media Science Fellow reporting on science issues for The Washington Star, in Washington, D.C.

Harris is co-founder of the Washington, D.C., Area Science Writers Association, as well as past president of the National Association of Science Writers.

A California native, Harris was valedictorian of his college graduating class at the University of California at Santa Cruz in 1980. He earned a bachelor's degree in biology, with highest honors.

Healthy women with normal pregnancies can opt to have labor induced without worrying that the decision will make a cesarean section more likely, according to a major study published in this week's New England Journal of Medicine.

Most drugs have side effects, but sometimes they're actually good news.

Researchers are now exploring whether some cheap and common drugs have side effects that could help people fight off the flu and other lung infections.

New advances in medicine also tend to come with a hefty dose of hype. Yes, some new cancer drugs in the hot field of precision medicine, which takes into account variables for individual patients, have worked remarkably well for some patients. But while many patients clamor for them, they aren't currently effective for the vast majority of cancers.

One of the enduring mysteries of biology is why so much of the DNA in our chromosomes appears to be simply junk. In fact, about half of the human genome consists of repetitive bits of DNA that cut and paste themselves randomly into our chromosomes, with no obvious purpose.

A study published Thursday finds that some of these snippets may actually play a vital role in the development of embryos.

For many years, the death rate from cancer climbed steadily, and the focus of big cancer meetings was the quest for better treatments to bring malignancies under control. Cancer death rates have been falling in recent decades, and that's allowed researchers to ask another important question: Are some people getting too much treatment for their cancers?

The answer, from the American Society of Clinical Oncology meeting in Chicago these past few days, is an emphatic yes.

If you go to the hospital for medical treatment and scientists there decide to use your medical information to create a commercial product, are you owed anything as part of the bargain?

That's one of the questions that is emerging as researchers and product developers eagerly delve into digital data such as CT scans and electronic medical records, making artificial-intelligence products that are helping doctors to manage information and even to help them diagnose disease.

Artificial intelligence, which is bringing us everything from self-driving cars to personalized ads on the web, is also invading the world of medicine.

In radiology, this technology is increasingly helping doctors in their jobs. A computer program that assists doctors in diagnosing strokes garnered approval from the U.S. Food and Drug Administration earlier this year. Another that helps doctors diagnose broken wrists in X-ray images won FDA approval on May 24.

Updated 12:43 p.m. ET

Perhaps 5,000 people died in Puerto Rico in 2017 for reasons related to September's Hurricane Maria, according to a study that dismisses the official death toll of 64 as "a substantial underestimate."

A research team led by scientists at the Harvard T.H. Chan School of Public Health didn't simply attempt to count dead bodies in the wake of the powerful storm. Instead, they surveyed randomly chosen households and asked the occupants about their experiences.

Scientists have launched two large studies to test a medical treatment that, if proven effective, could have an enormous impact on the leading cause of death in American hospitals.

The treatment is aimed at sepsis, a condition in which the body's inflammatory response rages out of control in reaction to an infection, often leading to organ damage or failure. There's no proven cure for sepsis, which strikes well over 1 million Americans a year and kills more than 700 a day.

Doctors encounter all nature of odd things in their daily lives. Sometimes the stories end up as more than coffee-room chatter. Consider a case that spills over from the clinical to the culinary: the hot pepper and the horrible headache.

Pages